Profile
Timothy Powers served as the Chief Executive Officer & Director at TabacaleraYsidron, Inc. and as the Chief Executive Officer at Mount Tam Biotechnologies, Inc. He also worked as the Director-Medicinal Chemistry at Amgen, Inc. and Alantos Pharmaceuticals Holding, Inc. Dr. Powers was also the Director & Chief Scientific Officer at Mount TAM Biotechnologies, Inc. He holds a doctorate degree from The University of Chicago and an undergraduate degree from the University of California, Davis.
Former positions of Timothy Powers
| Companies | Position | End |
|---|---|---|
Mount TAM Biotechnologies, Inc.
 Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Chief Executive Officer | 2016-02-07 |
| AMGEN INC. | Corporate Officer/Principal | 2011-12-31 |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 2006-12-31 |
Mount Tam Biotechnologies, Inc. /Old/
 Mount Tam Biotechnologies, Inc. /Old/ BiotechnologyHealth Technology Mount Tam Biotechnologies, Inc. develops medical compounds and treatment for autoimmune diseases. Its product TAM-01, focuses on the treatment of Systemic Lupus Erythematosus (SLE)-the most common form of lupus. The company was founded by Chester Aldridge, Mohammad Modarres and Stelios T. Tzannis on October 12, 2014 and is headquartered in Walnut Creek, CA. | Chief Executive Officer | - |
TabacaleraYsidron, Inc.
 TabacaleraYsidron, Inc. TobaccoConsumer Non-Durables TabacaleraYsidron, Inc. manufactures and distributes cigars. The company conducts its business principally through one operating subsidiary, Epicurean Cigars, Inc. It was founded by Steven J. Ysidron on November 8, 2011 and is headquartered in Chapel Hill, NC. | Chief Executive Officer | - |
Training of Timothy Powers
| University of California, Davis | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 4 |
|---|---|
TabacaleraYsidron, Inc.
TabacaleraYsidron, Inc. TobaccoConsumer Non-Durables TabacaleraYsidron, Inc. manufactures and distributes cigars. The company conducts its business principally through one operating subsidiary, Epicurean Cigars, Inc. It was founded by Steven J. Ysidron on November 8, 2011 and is headquartered in Chapel Hill, NC. | Consumer Non-Durables |
Mount Tam Biotechnologies, Inc. /Old/
Mount Tam Biotechnologies, Inc. /Old/ BiotechnologyHealth Technology Mount Tam Biotechnologies, Inc. develops medical compounds and treatment for autoimmune diseases. Its product TAM-01, focuses on the treatment of Systemic Lupus Erythematosus (SLE)-the most common form of lupus. The company was founded by Chester Aldridge, Mohammad Modarres and Stelios T. Tzannis on October 12, 2014 and is headquartered in Walnut Creek, CA. | Health Technology |
Mount TAM Biotechnologies, Inc.
Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Health Technology |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Stock Market
- Insiders
- Timothy Powers
